Frye Reginald F, Branch Robert A
Department of Pharmaceutical Sciences, School of Pharmacy, 807 Salk Hall, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Br J Clin Pharmacol. 2002 Feb;53(2):155-62. doi: 10.1046/j.1365-2125.2002.01522.x.
Short-term disulfiram administration has been shown to selectively inhibit CYP2E1 activity but the effects of chronic disulfiram administration on the activities of drug metabolizing enzymes is unclear. The purpose of this study was to evaluate the effects of disulfiram given for 11 days on selected drug metabolizing enzyme activities.
Seven healthy volunteers were given disulfiram 250 mg daily for 11 days. Activities of the drug metabolizing enzymes CYP1A2, CYP2C19, CYP2D6, CYP2E1 and N-acetyltransferase were determined using the probe drugs caffeine, mephenytoin, debrisoquine, chlorzoxazone, and dapsone, respectively. Chlorzoxazone was administered before disulfiram administration and after the second and eleventh doses of disulfiram, while the other probe drugs were given before disulfiram administration and after the eleventh disulfiram dose.
Disulfiram administration markedly inhibited chlorzoxazone 6-hydroxylation by more than 95%, but did not affect metabolism of debrisoquine or mephenytoin. Caffeine N3-demethylation was decreased by 34% (P < 0.05). Monoacetyldapsone concentrations were markedly elevated by disulfiram administration resulting in a nearly 16-fold increase in the dapsone acetylation index, calculated as the plasma concentration ratio of monoacetyldapsone to dapsone. CYP-mediated dapsone N-hydroxylation was not significantly altered.
These data suggest that disulfiram-mediated inhibition is predominantly selective for CYP2E1. The magnitude of CYP2E1 inhibition was similar after both acute and chronic disulfiram administration. The effects on caffeine N3-demethylation (CYP1A2) and dapsone metabolism suggest that chronic disulfiram administration may affect multiple drug metabolizing enzymes, which could potentially complicate the use of chronically administered disulfiram as a diagnostic inhibitor of CYP2E1.
短期给予双硫仑已显示可选择性抑制CYP2E1活性,但长期给予双硫仑对药物代谢酶活性的影响尚不清楚。本研究的目的是评估给予双硫仑11天对选定药物代谢酶活性的影响。
7名健康志愿者每天服用250mg双硫仑,共11天。分别使用探针药物咖啡因、美芬妥英、异喹胍、氯唑沙宗和氨苯砜测定药物代谢酶CYP1A2、CYP2C19、CYP2D6、CYP2E1和N-乙酰转移酶的活性。氯唑沙宗在给予双硫仑前以及给予双硫仑第二剂和第十一剂后给药,而其他探针药物在给予双硫仑前以及给予双硫仑第十一剂后给药。
给予双硫仑显著抑制氯唑沙宗6-羟基化超过95%,但不影响异喹胍或美芬妥英的代谢。咖啡因N3-去甲基化降低了34%(P<0.05)。给予双硫仑后单乙酰氨苯砜浓度显著升高,导致氨苯砜乙酰化指数(以单乙酰氨苯砜与氨苯砜的血浆浓度比计算)增加近16倍。CYP介导的氨苯砜N-羟基化没有显著改变。
这些数据表明双硫仑介导的抑制主要对CYP2E1具有选择性。急性和长期给予双硫仑后,CYP2E1抑制的程度相似。对咖啡因N3-去甲基化(CYP1A2)和氨苯砜代谢的影响表明,长期给予双硫仑可能会影响多种药物代谢酶,这可能会使长期使用双硫仑作为CYP2E1的诊断抑制剂变得复杂。